West Pharmaceutical Servi... (WST)
222.07
-3.99 (-1.77%)
At close: Mar 28, 2025, 3:59 PM
220.91
-0.52%
After-hours: Mar 28, 2025, 06:51 PM EDT
West Pharmaceutical Services Inc. Revenue Breakdown
| Quarter | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Mar 31, 2023 | Dec 31, 2022 | Mar 31, 2022 | Dec 31, 2021 | Mar 31, 2021 |
|---|---|---|---|---|---|---|---|---|---|
| Contract Manufactured Products Revenue | 145.5M | 142.4M | 135.9M | 419M | 133.5M | 361.7M | 118.7M | 387.6M | 127.1M |
| Contract Manufactured Products Revenue Growth | +2.18% | +4.78% | -67.57% | +213.86% | -63.09% | +204.72% | -69.38% | +204.96% | n/a |
Revenue by Geography
| Quarter | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 | Dec 31, 2017 | Dec 31, 2016 | Dec 31, 2015 | Dec 31, 2014 | Dec 31, 2013 | Dec 31, 2012 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| France Revenue | 282.9M | 237.9M | 213M | 172.7M | 150.6M | 127.5M | 125.6M | 116.3M | 107.6M | 118.2M | 112.6M | 102.6M |
| France Revenue Growth | +18.92% | +11.69% | +23.34% | +14.67% | +18.12% | +1.51% | +8.00% | +8.09% | -8.97% | +4.97% | +9.75% | n/a |
| Germany Revenue | 406.1M | 398.7M | 474.3M | 282.1M | 236.3M | 235.9M | 226.4M | 200.6M | 194M | 219.4M | 219.6M | 184.4M |
| Germany Revenue Growth | +1.86% | -15.94% | +68.13% | +19.38% | +0.17% | +4.20% | +12.86% | +3.40% | -11.58% | -0.09% | +19.09% | n/a |
| Ireland Revenue | 285.7M | 240.3M | 247.6M | 226M | 173.8M | 766.1M | 734.6M | 738.3M | 667.4M | 655.5M | 614.5M | 592.8M |
| Ireland Revenue Growth | +18.89% | -2.95% | +9.56% | +30.03% | -77.31% | +4.29% | -0.50% | +10.62% | +1.82% | +6.67% | +3.66% | n/a |
| United States Revenue | 1.24B | 1.29B | 1.2B | 975.6M | 814.7M | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| United States Revenue Growth | -3.73% | +7.39% | +22.80% | +19.75% | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expense Breakdown
| Quarter | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 85.3M | 83.5M | 83M | 86.7M | 90M | 89M | 88.4M | 86M | 85.7M | 66.3M | 81.5M | 83.4M | 98M | 91.9M | 92.7M | 80.2M | 76.3M | 76.2M | 77.7M | 71.8M | 69M | 64.8M | 70.3M | 68.6M | 59.7M | 64.9M | 70M | 68.3M | 58.9M | 61.5M | 60.6M | 61.6M | 60.9M | 58.3M | 62.5M | 58.1M | 62.4M | 54.6M | 71.7M | 55.2M |
| Selling, General, and Administrative Revenue Growth | +2.16% | +0.60% | -4.27% | -3.67% | +1.12% | +0.68% | +2.79% | +0.35% | +29.26% | -18.65% | -2.28% | -14.90% | +6.64% | -0.86% | +15.59% | +5.11% | +0.13% | -1.93% | +8.22% | +4.06% | +6.48% | -7.82% | +2.48% | +14.91% | -8.01% | -7.29% | +2.49% | +15.96% | -4.23% | +1.49% | -1.62% | +1.15% | +4.46% | -6.72% | +7.57% | -6.89% | +14.29% | -23.85% | +29.89% | n/a |
| Research and Development Revenue | 18.5M | 15.5M | 17.5M | 17.6M | 18.4M | 16.4M | 16.5M | 17.1M | 15.9M | 13.6M | 14.4M | 14.6M | 13.7M | 13.1M | 13.8M | 12.2M | 12.9M | 12.5M | 10.8M | 10.7M | 10.2M | 9.3M | 9.6M | 9.8M | 9.8M | 10.1M | 10.8M | 9.6M | 9.7M | 9.1M | 10M | 10.3M | 9.6M | 9M | 8.8M | 9.4M | 10M | 8.5M | 8.1M | 7.5M |
| Research and Development Revenue Growth | +19.35% | -11.43% | -0.57% | -4.35% | +12.20% | -0.61% | -3.51% | +7.55% | +16.91% | -5.56% | -1.37% | +6.57% | +4.58% | -5.07% | +13.11% | -5.43% | +3.20% | +15.74% | +0.93% | +4.90% | +9.68% | -3.12% | -2.04% | n/a | -2.97% | -6.48% | +12.50% | -1.03% | +6.59% | -9.00% | -2.91% | +7.29% | +6.67% | +2.27% | -6.38% | -6.00% | +17.65% | +4.94% | +8.00% | n/a |